Eric D. Shaff
Board Member
Seres Therapeutics, Inc. (MCRB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric D. Shaff
Eric D. Shaff is recorded as Board Member at Seres Therapeutics, Inc. (MCRB). Seres Therapeutics, Inc. reported in an 8-K filed July 22, 2025 that Eric D. Shaff resigned as President and Chief Executive Officer, effective July 31, 2025. The proxy statement of Seres Therapeutics, Inc. reports total compensation of $1,775,549 for Eric D. Shaff in fiscal 2025, including a base salary of $408,333. Disclosed compensation is on record for 8 fiscal years.
“On July 17, 2025, Eric D. Shaff, President, Chief Executive Officer and Director of Seres Therapeutics, Inc. (the "Company"), resigned from his positions as President and Chief Executive Officer of the Company, effective July 31, 2025 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2019-01-01–present
-
Start not stated–2025-07-31
-
Start not stated–2025-07-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Seres Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Marella Thorell CEO, CFO, Chief Accounting Officer
- Richard N. Kender CEO, Chairman, Board Member
- Roger J. Pomerantz CEO
- Kelly Brady COO
- Kelly Brady, M.S. COO
- David S. Ege CTO
- David Arkowitz Chief Accounting Officer
- Eric Shaff Chief Accounting Officer
- Claire Fraser, Ph.D. Board Member
- Claire M. Fraser, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Seres Therapeutics, Inc. (MCRB) | Former President and Chief Executive Officer | $408,333 | $1,775,549 |
| 2024 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $685,000 | $2,682,007 |
| 2023 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $685,000 | $3,158,336 |
| 2022 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $661,600 | $4,006,248 |
| 2021 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $625,400 | $9,711,680 |
| 2020 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $590,000 | $3,135,900 |
| 2019 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $540,000 | $2,032,548 |
| 2018 | Seres Therapeutics, Inc. (MCRB) | President and Chief Executive Officer | $435,000 | $1,447,070 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.